Koninklijke Philips (PHG) Cash from Financing Activities (2009 - 2026)
Koninklijke Philips' (PHG) quarterly Cash from Financing Activities came in at -$26.9 million in Q1 2026, up 46.67% year-on-year from -$18.4 million in Q1 2025, and up 92.82% quarter-over-quarter from -$374.8 million in Q4 2025.
Koninklijke Philips (PHG) Cash from Financing Activities (2009 - 2026) Analysis & Trends
Koninklijke Philips' Cash from Financing Activities history runs 18 years deep, the most recent figure standing at -$26.9 million for Q1 2026.
- On a quarterly basis, Cash from Financing Activities rose 46.67% year-over-year to -$26.9 million in Q1 2026; TTM through Mar 2026 was $717.8 million, a 258.02% increase from a year earlier, with the FY2025 full-year figure at $124.6 million, up 123.5% from the prior year.
- Cash from Financing Activities grew to -$26.9 million in Q1 2026 per PHG's latest filing, from -$374.8 million in the prior quarter.
- Across five years, Cash from Financing Activities topped out at $618.0 million in Q2 2025 and bottomed at -$912.4 million in Q4 2023.
- The 5-year median for Cash from Financing Activities is -$92.1 million (2024), against an average of -$49.4 million.
- Across the five-year window, Cash from Financing Activities slumped 149.12% in 2023 and jumped 378.44% in 2024, its largest moves.
- Year by year, Cash from Financing Activities stood at $372.4 million in 2022, then sank by 345.0% to -$912.4 million in 2023, then surged by 36.87% to -$576.0 million in 2024, then surged by 34.92% to -$374.8 million in 2025, then soared by 92.82% to -$26.9 million in 2026.
- Per Business Quant, the three latest PHG Cash from Financing Activities figures stand at -$26.9 million (Q1 2026), -$374.8 million (Q4 2025), and $501.5 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Financing Activities (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 17.31 Bn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | -1.51 Bn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | -888.00 Mn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | -260.00 Mn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | -451.20 Mn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | -25.00 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | -26.93 Mn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 21.00 Mn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | Steris | 20.59 Bn | 20.16 Bn | 697.10 Mn | -97.90 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -26.93 Mn |
| Mar 31, 2026 | -26.93 Mn |
| Dec 31, 2025 | -374.82 Mn |
| Dec 31, 2025 | -374.82 Mn |
| Sep 30, 2025 | 501.52 Mn |
| Sep 30, 2025 | 501.52 Mn |
| Jun 30, 2025 | 618.05 Mn |
| Jun 30, 2025 | 618.05 Mn |
| Mar 31, 2025 | -50.49 Mn |
| Mar 31, 2025 | -50.49 Mn |
| Dec 31, 2024 | -575.97 Mn |
| Dec 31, 2024 | -575.97 Mn |
| Sep 30, 2024 | -337.15 Mn |
| Sep 30, 2024 | -337.15 Mn |
| Jun 30, 2024 | 509.37 Mn |
| Jun 30, 2024 | 509.37 Mn |
| Mar 31, 2024 | -133.62 Mn |
| Mar 31, 2024 | -133.62 Mn |
| Dec 31, 2023 | -912.40 Mn |
| Dec 31, 2023 | -912.40 Mn |